Anagram Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
6
Anagram Therapeutics General Information
Description
Developer of orally-delivered enzyme therapeutics designed for the treatment of rare, life-threatening diseases. The company leverages proprietary enzyme technologies and expertise in gastrointestinal diseases, treats malabsorption syndromes and nutrient metabolism disorders that prevent the body from properly processing or absorbing certain fats, sugars, proteins, vitamins, or other key nutrients, enabling medical practitioners to address a major unmet need associated with the treatment of malabsorption and exocrine pancreatic insufficiency.
Contact Information
Website
www.anagramtx.comCorporate Office
- 33 Strathmore Road
- Natick, MA 01760
- United States
Corporate Office
- 33 Strathmore Road
- Natick, MA 01760
- United States
Anagram Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anagram Therapeutics Comparisons
Industry
Financing
Details
Anagram Therapeutics Competitors (87)
One of Anagram Therapeutics’s 87 competitors is Casma Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Casma Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Regenerx | Formerly VC-backed | Rockville, MD | ||||
| Glycomine | Venture Capital-Backed | San Carlos, CA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA |
Anagram Therapeutics Patents
Anagram Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025209470-A1 | Methods and compositions for treating congenital sucrase-isomaltase deficiency | Pending | 17-Jan-2024 | ||
| WO-2025155915-A1 | Methods and compositions for treating congenital sucrase-isomaltase deficiency | Pending | 17-Jan-2024 | ||
| AU-2023305628-A1 | Methods and compositions for treating congenital sucrase-isomaltase deficiency | Pending | 13-Jul-2022 | ||
| EP-4555081-A1 | Methods and compositions for treating congenital sucrase-isomaltase deficiency | Pending | 13-Jul-2022 | ||
| EP-4555081-A4 | Methods and compositions for treating congenital sucrase-isomaltase deficiency | Pending | 13-Jul-2022 | C12N9/2451 |
Anagram Therapeutics Signals
Anagram Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Anagram Therapeutics FAQs
-
When was Anagram Therapeutics founded?
Anagram Therapeutics was founded in 2017.
-
Where is Anagram Therapeutics headquartered?
Anagram Therapeutics is headquartered in Natick, MA.
-
What is the size of Anagram Therapeutics?
Anagram Therapeutics has 38 total employees.
-
What industry is Anagram Therapeutics in?
Anagram Therapeutics’s primary industry is Drug Discovery.
-
Is Anagram Therapeutics a private or public company?
Anagram Therapeutics is a Private company.
-
What is the current valuation of Anagram Therapeutics?
The current valuation of Anagram Therapeutics is .
-
What is Anagram Therapeutics’s current revenue?
The current revenue for Anagram Therapeutics is .
-
How much funding has Anagram Therapeutics raised over time?
Anagram Therapeutics has raised $278M.
-
Who are Anagram Therapeutics’s investors?
Blackstone, Miller Family Wine Brands, Cystic Fibrosis Foundation, and ABI LAB have invested in Anagram Therapeutics.
-
Who are Anagram Therapeutics’s competitors?
Casma Therapeutics, Alzheon, Regenerx, Glycomine, and AnTolRx are some of the 87 competitors of Anagram Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process